acut
respiratori
infect
ari
common
respiratori
diseas
continu
pose
threat
public
health
accord
report
publish
world
health
organ
lower
respiratori
infect
kill
million
peopl
deadli
communic
diseas
caus
million
death
worldwid
http
virus
major
etiolog
agent
ari
respiratori
syncyti
viru
rsv
human
metapneumovirus
hmpv
human
parainfluenza
virus
hpiv
classifi
subfamili
pneumovirina
paramyxovirina
paramyxovirida
nonseg
rna
common
caus
agent
ari
human
age
virus
caus
acut
respiratori
diseas
croup
bronchiol
pneumonia
children
elderli
immunodefici
patient
rsv
two
subtyp
subtyp
b
play
import
role
respiratori
infect
account
case
bronchiol
children
year
age
follow
rsv
children
respiratori
infect
hospit
bronchiol
caus
hpiv
four
subtyp
includ
consid
less
import
preval
acut
respiratori
infect
children
year
may
account
rsv
hmpv
hpiv
infect
caus
fever
cough
hypoxia
sever
symptom
bronchiol
therefor
difficult
distinguish
rsv
hmpv
hpiv
infect
accur
earli
diagnosi
base
clinic
manifest
seriou
earli
diagnosi
recogn
import
way
facilit
earli
manag
combat
polymeras
chain
reaction
pcr
detect
quantifi
specif
dna
rna
sampl
wide
use
detect
respiratori
virus
provid
effect
solut
earli
compar
tradit
viru
cultur
immunofluoresc
detect
method
pcr
advantag
high
sensit
short
turnaround
time
simultan
detect
multipl
pathogen
unlik
monoplex
pcr
multiplex
pcr
allow
multipl
pathogen
detect
simultan
singl
reaction
thu
advantag
time
save
present
sever
monoplex
multiplex
method
hmpv
rsv
hpiv
detect
establish
howev
techniqu
involv
simultan
detect
common
respiratori
paramyxovirus
especi
hmpv
perform
clinic
evalu
develop
triplex
assay
assess
sensit
specif
hmpv
new
method
use
detect
virus
hospit
patient
ari
perform
compar
commerci
routin
pathofind
maastricht
netherland
specimen
divid
two
group
accord
differ
purpos
one
group
posit
clinic
sampl
hmpv
ident
specimen
confirm
use
establish
method
use
provid
target
gene
construct
rna
standard
group
includ
nasopharyng
swab
patient
acut
febril
respiratori
syndrom
afr
admit
design
hospit
qinghai
provinc
may
may
evalu
clinic
method
specimen
mention
kept
laboratori
develop
triplex
assay
simultan
detect
common
respiratori
paramyxovirus
one
tube
set
detect
second
tube
set
detect
hmpv
sequenc
inform
primer
probe
triplex
present
support
inform
tabl
along
target
gene
reaction
concentr
label
screen
optim
six
common
respiratori
paramyxoviru
primer
probe
previou
primer
express
softwar
version
appli
biosystem
foster
citi
ca
use
modifi
sequenc
oligo
version
molecular
biolog
insight
colorado
spring
co
use
ensur
primer
complement
primer
dimer
exist
among
differ
virus
tube
dna
plasmid
clone
produc
viru
insert
fragment
contain
assay
target
plasmid
vector
easi
promega
madison
wi
plasmid
amplifi
quanshijin
beij
china
insert
gene
sequenc
rna
standard
obtain
vitro
transcript
use
larg
scale
rna
product
promega
southampton
uk
purifi
use
rneasi
mini
kit
qiagen
hilden
germani
rna
standard
quantifi
three
time
use
nanodrop
spectrophotomet
nanodrop
technolog
wilmington
de
number
copi
per
calcul
use
mean
valu
formula
rna
length
length
number
nucleotid
dilut
equival
rna
use
calcul
limit
detect
triplex
commerci
avail
qiaamp
minelut
viru
rotat
kit
qiagen
use
extract
dna
rna
total
total
nucleic
acid
extract
clinic
specimen
sampl
neg
water
control
includ
everi
run
triplex
perform
use
primescript
kit
takara
osaka
japan
contain
buffer
iii
primescript
rt
enzym
mix
takara
ex
taq
hs
variabl
concentr
primer
probe
indic
supplement
tabl
nucleic
acid
templat
final
volum
reaction
incub
follow
minut
revers
transcript
second
denatur
cycl
second
minut
assay
perform
lightcycl
roch
mannheim
germani
qiagen
water
use
neg
control
monoplex
detect
individu
human
paramyxoviru
previou
set
primer
probe
chang
three
one
concentr
modifi
reaction
condit
chang
commerci
kit
routin
assay
pathofind
appli
studi
compar
perform
assay
detect
human
paramyxovirus
clinic
set
analyt
sensit
multiplex
assay
determin
test
serial
dilut
quantifi
rna
target
specif
multiplex
assay
determin
test
respiratori
virus
includ
human
coronaviru
influenza
viru
influenza
b
viru
rhinovirus
adenoviru
bocaviru
echoviru
check
consist
diagnosi
viru
experi
done
triplic
obtain
coeffici
variat
cv
linear
triplex
determin
use
graphpad
prism
softwar
graphpad
p
consid
statist
signific
project
approv
institut
review
board
centr
diseas
control
prevent
china
individu
written
inform
consent
obtain
parent
guardian
particip
number
rna
transcript
copi
viru
use
serial
logarithm
dilut
determin
nanodrop
nanodrop
technolog
inc
follow
concentr
appli
determin
linear
triplex
three
replic
test
concentr
singl
run
amplif
typic
standard
curv
plot
cycl
threshold
c
valu
vertic
axi
lg
horizont
axi
provid
inform
amplif
effici
theoret
detect
limit
assay
support
inform
figur
correl
coeffici
r
measur
linear
regress
greater
hmpv
triplex
limit
detect
viru
triplex
assay
copi
per
reaction
shown
support
inform
figur
previou
research
shown
primer
probe
appli
triplex
perform
good
meanwhil
test
show
combin
specif
viru
coronaviru
influenza
viru
influenza
b
viru
rhinovirus
adenoviru
bocaviru
echoviru
use
diethyl
pyrocarbon
water
neg
control
result
show
tube
among
three
target
virus
precis
estim
perform
triplex
assay
per
day
day
use
protocol
reagent
assess
variat
three
concentr
viru
test
five
time
per
run
hand
sampl
test
five
time
three
separ
run
assess
interassay
variat
result
show
cv
less
cv
rang
interassay
cv
rang
support
inform
tabl
total
clinic
specimen
patient
afr
test
use
triplex
monoplex
target
virus
detect
total
detect
posit
human
paramyxovirus
clinic
specimen
among
clinic
specimen
detect
highest
frequenc
case
posit
respect
one
case
posit
shown
tabl
although
mean
c
valu
vari
one
anoth
consist
observ
multiplex
monoplex
assay
result
six
virus
tabl
posit
specimen
studi
valid
base
nest
sequenc
data
shown
furthermor
posit
case
human
paramyxovirus
infect
singl
viru
composit
ratio
show
coinfect
tabl
common
pattern
coinfect
doubl
infect
case
tripl
infect
case
singl
infect
common
case
epidemiolog
afr
patient
human
paramyxovirus
infect
also
investig
studi
tabl
note
predominantli
detect
age
group
afr
year
frequent
detect
among
inpati
outpati
afr
season
distribut
also
observ
sever
human
paramyxovirus
sex
bia
shown
final
compar
perform
assay
commerci
kit
detect
human
paramyxovirus
clinic
set
tabl
data
show
posit
human
paramyxovirus
detect
among
clinic
specimen
patient
afr
significantli
lower
result
detect
multiplex
assay
especi
detect
analysi
indic
discord
result
mainli
due
low
level
pathogen
higher
c
c
conclud
multiplex
assay
show
better
perform
higher
sensit
commerci
kit
detect
human
paramyxovirus
clinic
set
hmpv
rsv
togeth
hpiv
belong
paramyxovirida
famili
classifi
pneumovirina
subfamili
paramyxovirina
subfamili
paramyxovirida
nonseg
rna
detect
rate
high
ari
particularli
infant
children
indic
import
clinic
signific
acut
respiratori
ill
multiplex
pcr
fast
techniqu
diagnos
respiratori
viral
infect
howev
studi
attempt
use
method
quickli
simultan
detect
six
known
common
human
paramyxovirus
includ
recent
identifi
hmpv
develop
triplex
detect
virus
use
routin
laboratori
diagnost
evalu
triplex
clinic
sampl
analyz
use
establish
method
studi
determin
total
detect
rate
paramyxoviru
infect
afr
popul
qinghai
combin
multipl
primer
probe
one
reaction
may
affect
sensit
assay
interact
may
reduc
avail
specif
primer
addit
presenc
multipl
target
one
reaction
may
result
competit
enzym
analysi
hmpv
rsv
hpiv
rna
standard
dynam
rang
show
sensit
reduct
new
trial
standard
curv
show
viru
perform
well
monoplex
triplex
reaction
detect
limit
copi
viru
gene
per
reaction
literatur
report
copi
viru
gene
hmpv
infect
dose
curv
paramet
r
slope
indic
good
linear
effici
process
amplif
assess
cv
within
intragroup
intergroup
assay
reflect
degre
variat
data
result
show
stabl
state
intra
interexperi
reaction
studi
predomin
detect
virus
highli
concord
previou
total
case
simultan
detect
coinfect
human
paramyxovirus
individu
specimen
confirm
superior
multiplex
detect
c
valu
also
suggest
differ
human
paramyxovirus
afr
patient
differ
viral
load
moreov
compar
perform
assay
monoplex
commerci
kit
detect
human
paramyxovirus
clinic
set
consist
result
superior
sensit
sever
pathogen
indic
method
develop
applic
potenti
clinic
sampl
studi
limit
small
sampl
size
studi
hinder
abil
accur
assess
season
pathogen
includ
studi
nonetheless
result
suggest
human
paramyxovirus
commonli
detect
autumn
winter
conclus
first
develop
novel
multiplex
assay
rapid
detect
six
common
human
paramyxovirus
domin
patient
afr
qinghai
second
method
provid
new
approach
higher
qualiti
perform
accuraci
speed
higher
sensit
detect
common
respiratori
paramyxovirus
clinic
set
triplex
pcr
assay
provid
sever
advantag
without
compromis
qualiti
compar
monoplex
commerci
routin
author
declar
conflict
interest
pn
wt
conceiv
design
experi
gl
pn
rl
perform
experi
gl
wt
analyz
data
gl
wt
wrote
manuscript
